Fermenta Biotech Ltd

Established in 1951, DIL Limited (earlier known as Duphar-Interfran Limited) is a publicly-listed company that has developed a unique standing in the businesses of pharmaceuticals, biotechnology, environmental solutions and other segments.(Source : 201983 Annual Report Page No: 6)

  • Market Cap: 716.50 Cr.
  • Current Price: 243.45
  • 52 weeks High / Low 337.00 / 151.00
  • Book Value: 101.14
  • Stock P/E: 12.11
  • Dividend Yield: 0.68 %
  • ROCE: -1.56 %
  • ROE: 6.07 %
  • Sales Growth (3Yrs): 46.61 %
  • Listed on BSE
  • Company Website
  • Face Value: 5.00
Edit ratios
Pros:
Company has good consistent profit growth of 21.80% over 5 years
Cons:
Company has low interest coverage ratio.
Promoter holding has decreased by -2.51% over last quarter
Company has a low return on equity of -17.12% for last 3 years.

Peer comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs

Loading peers table ...

Quarterly Results Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019
1 2 3 3 5 5 121 112 5 5 81 66
4 4 4 4 10 4 84 67 4 4 65 53
Operating Profit -3 -2 -1 -1 -5 0 37 45 1 2 16 14
OPM % -193% -133% -27% -32% -112% 8% 31% 40% 18% 29% 19% 21%
Other Income 0 0 0 0 0 0 9 1 0 0 5 3
Interest 1 2 3 2 4 4 5 6 4 4 5 5
Depreciation 1 1 1 1 1 1 3 3 1 1 4 4
Profit before tax -5 -5 -5 -4 -10 -4 39 37 -4 -3 12 8
Tax % -2% -0% -0% -0% -7% -0% 30% 25% 573% 35% -168% -19%
Net Profit -5 -5 -5 -4 -10 -4 27 28 19 -2 33 10
EPS in Rs -1.75 -1.78 -1.81 -1.41 -0.94 -1.60 9.48 3.24 6.90 -0.81 3.77 1.13
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
9 12 21 15 18 18 15 14 6 6 13 19 158
6 8 10 10 7 9 11 11 13 14 22 19 126
Operating Profit 3 4 11 5 11 9 4 3 -6 -8 -9 0 32
OPM % 35% 36% 51% 34% 60% 50% 28% 21% -106% -154% -75% 1% 20%
Other Income 1 2 1 23 9 0 0 0 1 0 0 -6 9
Interest 0 1 0 0 0 0 0 0 2 6 11 16 18
Depreciation 1 1 1 1 2 2 2 2 2 3 4 4 9
Profit before tax 3 4 10 27 18 7 2 1 -9 -18 -23 -26 13
Tax % 4% 17% 26% 20% 20% 20% 31% 30% 1% -2% -3% 90%
Net Profit 3 3 8 22 15 5 1 1 -9 -18 -24 -3 59
EPS in Rs 0.80 1.03 2.56 7.55 4.92 1.63 0.37 0.18 0.00 0.00 0.00 0.00 10.99
Dividend Payout % 88% 101% 45% 26% 47% 96% 161% 157% -6% -3% -2% -43%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:4.71%
5 Years:4.96%
3 Years:46.61%
TTM:-34.87%
Compounded Profit Growth
10 Years:0.95%
5 Years:21.80%
3 Years:34.24%
TTM:45.80%
Stock Price CAGR
10 Years:27.24%
5 Years:38.77%
3 Years:64.35%
1 Year:-17.00%
Return on Equity
10 Years:-2.02%
5 Years:-11.55%
3 Years:-17.12%
Last Year:6.07%

Balance Sheet Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Sep 2019
2 2 2 2 2 2 2 2 2 2 2 5 5
Reserves 68 67 71 86 93 92 91 90 80 87 62 55 293
Borrowings 0 0 0 2 6 1 25 35 52 44 143 147 208
10 11 11 9 9 13 13 15 15 12 15 27 126
Total Liabilities 80 81 85 99 110 107 131 143 149 146 223 233 633
10 13 13 13 12 10 8 7 93 94 96 93 197
CWIP 1 0 0 0 5 13 34 63 1 1 0 0 50
Investments 51 49 47 59 36 32 39 40 41 40 118 108 2
18 18 25 27 57 53 51 33 15 12 9 33 384
Total Assets 80 81 85 99 110 107 131 143 149 146 223 233 633

Cash Flows Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
8 5 -5 -3 31 11 2 -0 -5 -9 1 16
-7 -3 9 12 -25 -2 -20 -11 -8 20 -89 0
-1 -2 -4 -8 -7 -8 21 9 14 -13 88 -16
Net Cash Flow 0 0 -0 1 -0 1 2 -2 1 -2 1 -0

Ratios Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 4% 8% 14% 12% 10% 7% 2% 1% -5% -9% -7% -2%
Debtor Days 128 88 23 31 5 12 9 5 2 26 8 5
Inventory Turnover 81.78 40.04 33.76 30.04 27.29